Medical Marijuana Inc.'s HempMedsPX Leading the Industry

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Medical Marijuana Inc.'s HempMedsPX Leading the Industry With Hemp-Based Cannabidiol (CBD) Products

SAN DIEGO, Sept. 27, 2013 (GLOBE NEWSWIRE) -- Medical Marijuana Inc . (OTC Pink:MJNA) is pleased to inform shareholders and the general public that HempMedsPX —a corporate portfolio company of Medical Marijuana Inc. and the exclusive master distributor and contracted marketing company for CannaVest Corp. and Medical Marijuana Inc. — entered the "High CBD (cannabidiol) Award"-winning product at the High Times Medical Cannabis Cup in Seattle, Washington. Submitted by HempMedsPX on behalf of PhytoSPHERE Systems , the prototype product CBD Simple tested at a record 95.8% CBD, the highest CBD percentage ever documented at the Cannabis Cup.

All entries were tested by Analytical 360 and Northwest Botanical Analysis , the independent laboratories employed by the High Times Medical Cannabis Cup for this competition, and were further assessed by an expert panel for additional attributes such as taste, smell, and visual presentation. CBD Simple returned a CBD percentage of 95.8%, resulting in a sweep of the High CBD—Concentrates category. HempMedsPX received the confirmed test results earlier this week.

"The enthusiasm for high- CBD products at the Cup represents a huge shift in cannabis culture," said Chris Boucher, Vice President of Product Development for HempMedsPX . "This was the first time the company entered any products into a competition of this kind, and we are thrilled with the result. The support for what we are doing from the cannabis community was overwhelming."

Michael Mona Jr., President and CEO of CannaVest Corp., accepted the award in Seattle on behalf of PhytoSPHERE Systems and HempMedsPX . "We are very thankful for the hard work of our friends at HempMedsPX, and for the incredible PhytoSPHERE team that produced this game-changing product. We are excited to work together to bring standardized, hemp-based high CBD products to the market," said Mona Jr.

The two-day event was held in Seattle, Washington on September 7-8, 2013. To see the full results of the competition, please visit HighTimes.com .

For more information or to purchase hemp CBD products, please visit HempMedsPX.com or call 866-273-8502.

About HempMedsPX

HempMedsPX offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMedsPX is a corporate portfolio company of Medical Marijuana Inc . (OTC Pink:MJNA) and the exclusive master distributor and contracted marketing company for CannaVest Corp. (OTC:CANV) and Medical Marijuana Inc . In addition to handling sales and distribution of hemp cannabidiol (CBD) products, HempMedsPX is the communication hub for the Medical Marijuana Inc. family of companies.

About Medical Marijuana, Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company's website at:  www.MedicalMarijuanaInc.com

About CannaVest Corp.

CannaVest Corp. (OTC:CANV) is in the business of investing and developing hemp-based cannabinoid companies. CannaVest Corp. also develops, produces, markets and sells end-consumer products to the nutraceutical industry containing the hemp plant extract, cannabidiol (CBD). Additionally, the company resells—to third parties—raw product acquired by CannaVest Corp. pursuant to the company's supply relationships in Europe. CannaVest Corp. seeks to take advantage of an emerging worldwide trend to re-energize the production of industrial hemp and to foster its many uses for consumers. Cannabinoids (cannabidiol/CBD) are natural constituents of the hemp plant and CBD is derived from hemp stalk and seed. Additional information is available from OTCMarkets.com or by visiting CannaVest.com .

About PhytoSPHERE Systems

PhytoSPHERE Systems is a global phytocannabinoid biotechnology company based in San Diego, California with an exclusive license for use by CannaVest Corp. (OTC:CANV). The company utilizes advanced cultivation methods and state-of-the-art processing technology leading to development of pharmaceutical, nutraceutical and food products.

PhytoSPHERE Systems, the manufacturer of the CBD-rich hemp oil used in Real Scientific Hemp Oil (RSHO), has developed special cultivars (similar to "strains") that produce hemp that is especially rich in CBD, making it possible for PhytoSPHERE to offer all-natural products with high concentrations of hemp-based CBD. For more information, visit: PhytoSPHERESystems.com

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. and CannaVest Corp. to be materially different from the statements made herein.

LEGAL DISCLOSURE

Medical Marijuana, Inc., CannaVest Corp., and HempMedsPX do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell and distribute hemp-based products and are involved with Federally Legal Distribution of Medical Marijuana based products within certain international markets.

Investor relations contact: Stuart T. Smith SmallCapVoice.Com, Inc. P. 512-267-2430 Corporate contact: Medical Marijuana, Inc. Toll Free: 888-OTC-MJNA (888-682-6562) www.medicalmarijuanainc.com www.facebook.com/mjnainc

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 11

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 11

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 7

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 7

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 12

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 5

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 8

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 12

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 12

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding ADHD and the Role of RELEXXII in Treatment

Updated Category News Views 215

Supporting ADHD Awareness: The Role of RELEXXII This month marks a significant time for acknowledging and educating people about Attention Deficit Hyperactivity Disorder (ADHD). Alora Pharmaceuticals, the leading manufacturer behind RELEXXII® (methylphenidate hydrochloride extended-release tablet), is deeply committed to this cause. ADHD impacts various dimensions of...

Continue Reading
New Class Action Filed Against Paragon 28 Over Alleged Fraud

Updated Category News Views 111

Introduction to the New Class Action Against Paragon 28 Hagens Berman has recently taken action by filing a class action lawsuit against Paragon 28, Inc. (NYSE: FNA) alongside several of its senior executives. The case aims to hold the company accountable for alleged fraudulent activities affecting investors. Overview of the Allegations The lawsuit extends an ongoing...

Continue Reading
Subway Teams Up with ARC Raiders for Gaming Promo

Updated Category News Views 16

What’s Cooking Between Subway and Embark Studios? Subway’s diving headfirst into the gaming world, folks. It’s not a piece of cake to see a sandwich giant team up with a game studio, but today, Subway’s sidestepping the typical food deal. Instead, it's sharpening its digital claws with Embark Studios, a Stockholm-based game developer. They’re gearing up for the...

Continue Reading
CagriSema Breakthrough: Weight Loss Success in Adults

Updated Category News Views 312

Significant Weight Loss Achieved with CagriSema in Clinical Trial In recent findings, Novo Nordisk has unveiled compelling results from the extensive REDEFINE 1 trial, focusing on the innovative weight loss treatment, CagriSema. This clinical study assessed the efficacy of subcutaneous CagriSema—a fixed-dose combination of cagrilintide 2.4 mg and semaglutide 2.4 mg—in...

Continue Reading
Endor Labs Achieves Remarkable Growth in Application Security

Updated Category News Views 390

Endor Labs Shows Impressive Revenue Growth Endor Labs, a leader in application security, proudly announces a significant milestone: a whopping 225% year-over-year revenue growth. This achievement highlights the increasing demand for robust security measures that can keep pace with the rapid transformations in software development, especially given the rise of AI...

Continue Reading